Microrobots enable precise drug delivery and biopsy, overcoming low targeting efficiency, reducing toxicity, and potentially ...
Zacks Small Cap Research on MSN
ASBP: A platform approach to drug delivery with an unconventional path to commercialization
By David Bautz, PhD NASDAQ: ASBP Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is attempting something relatively uncommon ...
A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...
The FDA has approved the Control-IQ+ automated insulin delivery system for use in pregnant women with type 1 diabetes, ...
(Nanowerk Spotlight) Precision in drug delivery has long posed a significant challenge to the medical field. Relying on the body’s circulatory system to transport medications often results in ...
Scientists created a new drug delivery system that can receive commands wirelessly from a smartphone or computer to schedule and trigger the release of drugs from individual microneedles. The patch's ...
Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.
Stanford engineers have developed an injectable hydrogel depot technology that enables GLP-1 drugs to be administered once every four months, compared to repeated daily injections. Materials engineers ...
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...
Medical Device Network on MSN
Tandem secures FDA approval for Control-IQ+ use in pregnancy
The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results